Imexpharm Corporation (HOSE:IMP)

Imexpharm Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Jan 1, 2025	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	133,332	189,193	161,983	106,201	178,845	271,273
Short-Term Investments	389,225	212,102	142,000	93,000	211,300	111,300
Trading Asset Securities	-	-	-	-	-	1,153
Cash & Short-Term Investments	522,557	401,296	303,983	199,201	390,145	383,726
Cash Growth	32.04%	32.01%	52.60%	-48.94%	1.67%	157.75%
Accounts Receivable	453,874	323,278	334,746	254,058	228,770	241,946
Other Receivables	3,002	4,036	4,030	4,066	-1,000	11,995
Receivables	456,875	327,314	338,776	258,124	227,770	255,941
Inventory	687,618	677,715	705,082	699,446	435,841	492,075
Prepaid Expenses	-	21,304	15,564	6,539	1,601	3,155
Other Current Assets	53,991	79,783	46,139	43,825	48,195	41,443
Total Current Assets	1,721,042	1,507,411	1,409,544	1,207,135	1,103,553	1,176,340
Property, Plant & Equipment	703,347	745,246	828,489	908,754	996,450	955,680
Long-Term Investments	97,088	66,959	66,959	71,284	71,290	50,962
Other Intangible Assets	71,471	73,215	74,219	74,150	72,978	73,581
Other Long-Term Assets	1,054	389,804	125,566	131,293	32,672	38,136
Total Assets	2,959,303	2,782,634	2,504,777	2,392,615	2,276,944	2,294,700

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Jan 1, 2025	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021
Accounts Payable	94,249	80,783	77,044	70,505	87,542	92,713
Accrued Expenses	126,483	102,784	89,231	144,776	139,803	100,346
Short-Term Debt	111,605	112,779	86,122	49,422	-	80,491
Current Portion of Long-Term Debt	-	-	-	-	94,980	91,652
Current Income Taxes Payable	21,429	27,727	31,631	19,107	25,382	17,141
Current Unearned Revenue	46,338	-	-	-	-	-
Other Current Liabilities	30,491	48,360	37,630	24,227	34,789	26,295
Total Current Liabilities	430,595	372,432	321,657	308,036	382,497	408,638
Long-Term Debt	100,000	100,000	-	-	-	91,652
Other Long-Term Liabilities	3,680	3,680	-	-	-	-
Total Liabilities	534,275	476,112	321,657	308,036	382,497	500,290

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Jan 1, 2025	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021
Common Stock	1,540,428	1,540,428	1,540,428	700,384	667,054	667,054
Additional Paid-In Capital	187,323	187,323	187,323	507,368	507,368	507,368
Retained Earnings	695,214	576,709	453,306	874,764	717,963	617,926
Treasury Stock	-358.6	-358.6	-358.6	-358.6	-358.6	-358.6
Comprehensive Income & Other	2,421	2,421	2,421	2,421	2,421	2,421
Shareholders' Equity	2,425,028	2,306,522	2,183,119	2,084,579	1,894,447	1,794,410
Total Liabilities & Equity	2,959,303	2,782,634	2,504,777	2,392,615	2,276,944	2,294,700

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Jan 1, 2025	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021
Total Debt	211,605	212,779	86,122	49,422	94,980	263,795
Net Cash (Debt)	310,952	188,516	217,862	149,779	295,165	119,931
Net Cash Growth	1263.84%	-13.47%	45.46%	-49.26%	146.11%	568.18%
Net Cash Per Share	2019.05	1224.06	1414.60	972.53	1916.53	778.71
Filing Date Shares Outstanding	154.01	154.01	154.01	154.01	154.01	154.01
Total Common Shares Outstanding	154.01	154.01	154.01	154.01	154.01	154.01
Working Capital	1,290,447	1,134,979	1,087,886	899,099	721,056	767,702
Book Value Per Share	15746.02	14976.55	14175.27	13535.33	12300.70	11651.16
Tangible Book Value	2,353,557	2,233,308	2,108,900	2,010,429	1,821,469	1,720,829
Tangible Book Value Per Share	15281.95	14501.15	13693.36	13053.86	11826.85	11173.39
Buildings	386,519	385,312	384,650	384,597	299,061	298,602
Machinery	1,127,309	1,101,466	1,088,549	1,066,310	638,041	601,972
Construction In Progress	42,444	37,418	43,897	47,351	580,743	519,463

Data Source: S&P Global Market Intelligence Last updated: Oct 20, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error